HCPLive | American Journal of Managed Care | American Journal of Pharmacy Benefits | Pharmacy Times | OTCGuide | Campaigns & Elections
ONCLive | Physicians Money Digest | iMedicalApps | Medgadget | EchoJournal | Dr.Pullen | Medical Smartphones | Medicine and Technology
Mobile Health Computing | Non-Clinical Medical Jobs, Careers, and Opportunities | ShrinkRap | Psychiatry Talk
 
Register   |   Login
 
 
   oncology   >  P-2
 
 
Leading oncologists from Memorial Sloan-Kettering Cancer Center offered insight about neuroendocrine tumors, non-small cell lung cancer, HPV, and mesothelioma. Click below to read the article and watch the corresponding video:
 
 
 
   
Oncology Multimedia
 
Oncolog-e Nurse Talk
Colleen O'Leary, RN, MSN, AOCNS

Want To Know or Right To Know
Every so often this issue comes up again and the discussion ensues as to whether or not to tell a patient about their terminal diagnosis. Most often, people agree that, even if the family doesn’t want the patient to know that their diagnosis is terminal, it is the patient’s right to know.


The Women's Cancer Blog
Don S. Dizon, MD, FACP

Cost-Utility Analysis and Trastuzumab
Of the paradigms that govern the treatment of breast cancer that is most accepted is that of the treatment of metastatic breast cancer that is HER-2 positive. For these patients, chemotherapy with trastuzumab is the gold standard.


Current Issues Upcoming Issues  
 
The Missing Piece? Trying to Solve the Skin Cancer Puzzle
 
Advances in Preventing and Diagnosing Cervical Cancer
 
Back to the Future: Why Are More Women Having Bilateral Mastectomy for Unilateral Breast Cancer?
 
Highlights from the NCCN 15th Annual Conference
     
Medication Adherence Technologies: Promise or Pitfalls?
 
Melanoma: Improving Clinical Outcomes Through Advances in Immunotherapeutics and Targeted Therapy
 
Cancer fundraising gone too far? 
     
Current Treatment Options for Managing Chemotherapy-Induced Nausea and Vomiting

Pancreatic Cancer: Where do we go from here?

New Data and Shifting Practice Patterns for Maintenance Therapy in Advanced NSCLC

Treatment Options for Patients with Stage III and IV Melanoma

The mSMART Approach to Managing Multiple Myeloma: 2008 Update
Advertisement

Do you support federal legalization of medical marijuana?
Yes
No
Patient decision
 
   
Advertisement
  
   

Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747
Copyright ©MDNG 2006-2010
Intellisphere, LLC
All Rights Reserved